| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 04/15/2009 | CN101410406A 6-modified bicyclic nucleic acid analogs |
| 04/15/2009 | CN101407810A Small interfering RNA with midkine gene as target, vector and use thereof |
| 04/15/2009 | CN100478452C Genetic analysis and authentication |
| 04/15/2009 | CN100478443C High efficiency siRNA molecule to target gene Rig-G |
| 04/15/2009 | CN100478355C New human protein with mouse NIH/3T3 cell transformation improving function and its code sequence |
| 04/15/2009 | CN100478354C Novel human protein with cancer inhibiting function and its code sequence |
| 04/14/2009 | US7517979 Multidentate arrays |
| 04/14/2009 | US7517978 Modified oligonucleotides and applications thereof |
| 04/14/2009 | US7517977 Reagents and methods for improving reproducibility and reducing mispriming in PCR amplification |
| 04/14/2009 | US7517976 proteins and/or polypeptides encoded by DNA isolated from rna viruses, used as vaccines, for detection and treatment of swine infected with PRRSV |
| 04/14/2009 | US7517974 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders |
| 04/14/2009 | US7517973 Expression vector comprising nucleotide sequences coding astrocyte enhanced/suppressed gene sequences for use as tool in identifying modulators for treatment and prevention of viral-related nervous system disorders |
| 04/14/2009 | US7517972 Nucleic acid sequences encoding a bitter taste receptor, T2R76 |
| 04/14/2009 | US7517971 Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity |
| 04/14/2009 | US7517970 Using transgenic cells comprising nucleotide sequences coding tyrosine kinase/phosphatase fusion as tool indentifying enzyme inhibitors; drug screening; mimetics |
| 04/14/2009 | US7517969 Providing chaotrope, nucleic acid binding solid phase, NH3; contacting sample solid phase in presence of liquid phase comprising chaotropic agent; separate nucleic acid bound solid phase from liquid phase |
| 04/14/2009 | US7517967 Monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma |
| 04/14/2009 | US7517966 antibodies that bind polypeptides that are prefrentially expressed by all mature NK cells, used for medical diagnosis, prevention of viral and microbial infections, and as antitumor agents |
| 04/14/2009 | US7517956 insecticidal proteins isolated from gramnegative bacteria, used for controlling insects |
| 04/14/2009 | US7517952 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 04/14/2009 | US7517949 Livin-derived peptides, compositions and uses thereof |
| 04/14/2009 | US7517864 Study and interfererance, diagnosis and treatment of polyglutamine using short interfering nucleic acid for treatment of dementia or siezures or muscular dystrophy |
| 04/14/2009 | US7517863 Enhanced secretion/retention of growth hormone releasing hormone (GHRH) from muscle cells by species-specific signal peptide |
| 04/14/2009 | US7517861 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis |
| 04/14/2009 | US7517684 Nucleic acid and amino acid sequences relating to Pseudomonas aeruginosa for diagnostics and therapeutics |
| 04/14/2009 | US7517680 Production of clavulanic acid by genetic engineering of Streptomyces clavuligerus |
| 04/14/2009 | US7517679 Recombinant watermelon (Citrullus lanatus) hydroperoxide lyase and uses thereof |
| 04/14/2009 | US7517677 a polypeptide having a higher catalytic activity for oxidation of cephalosporin C to glutaryl-7-aminocephalosporanic acid, than that of the wild-type polypeptide |
| 04/14/2009 | US7517676 polynucleotide comprising a DNA sequence that codes for a polypeptide having oxidoreductase enzyme activity, used in detection assays, gene therapy, and screening assays |
| 04/14/2009 | US7517673 Process for producing alpha1,4-galactosyltransferase and galactose-containing complex carbohydrate |
| 04/14/2009 | US7517670 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 04/14/2009 | US7517668 Process for the production of protein products in aspergillus |
| 04/14/2009 | US7517663 Rabbit monoclonal antibody against Id1 protein |
| 04/14/2009 | US7517652 Methods of diagnosing tumors using the G-protein coupled receptor (GPCR), RAI-3 |
| 04/14/2009 | US7517650 Obtaining a nucleic acid from a female under age 41 or older than 54 and determining a nucleotide at a polymorphic site of the nucleic acid; polynucleotides specific to breast cancer, a microarray comprising the polynucleotides, and diagnostic kits; hybridization |
| 04/14/2009 | US7517648 NPHP nucleic acids and proteins |
| 04/14/2009 | US7517646 Provides functional molecule having an affinity and specificity to a target comparable to the affinity and specificity of an antibody against an antigen; modified oligonucleotide sequence |
| 04/14/2009 | US7517645 Detection of high grade dysplasia in cervical cells |
| 04/14/2009 | US7517644 Administering an expression vector, a double stranded oligodeoxynucleotide, or an antisense oligodeoxynucleotide to treat cancer, AIDS or other Aberrant Programming Disease; regulating expression of a transcriptional regulator; antiapoptosis |
| 04/14/2009 | US7517538 Solid supports functionalised with phosphorus dendrimers, method for preparing same and uses thereof |
| 04/14/2009 | US7517531 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 |
| 04/14/2009 | CA2277583C Large scale genotyping of diseases and a diagnostic test for spinocerebellar ataxia type 6 |
| 04/14/2009 | CA2259657C Identification of a transforming fragment of herpes simplex type 2 and detection thereof in clinical specimens |
| 04/14/2009 | CA2221279C Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide |
| 04/09/2009 | WO2009046395A2 Method to predict response to treatment for psychiatric illnesses |
| 04/09/2009 | WO2009046388A1 Cr-2 binding peptide p28 as molecular adjuvant for dna vaccines |
| 04/09/2009 | WO2009046141A2 Antisense modulation of fibroblast growth factor receptor 4 expression |
| 04/09/2009 | WO2009046104A1 Aptamer-targeted sirna to prevent attenuation or suppression of t cell function |
| 04/09/2009 | WO2009046080A1 N-terminal modified interferon-alpha |
| 04/09/2009 | WO2009045550A2 System for capturing and modifying large pieces of genomic dna and constructing organisms with synthetic chloroplasts |
| 04/09/2009 | WO2009045536A2 Receptor targeted oligonucleotides |
| 04/09/2009 | WO2009045467A1 Methods and compositions for identifying increased risk of developing fragile x-associated disorders |
| 04/09/2009 | WO2009045457A2 Tripartite rnai constructs |
| 04/09/2009 | WO2009045344A2 Error-free amplification of dna for clonal sequencing |
| 04/09/2009 | WO2009044085A2 Oligonucleotides, use, method of detection and kit for diagnosing the presence of the e1 gene of the chikungunya virus |
| 04/09/2009 | WO2009043184A1 Nucleotide modular assemblies and their use as delivery devices |
| 04/09/2009 | WO2009043182A1 Sequence-characterized amplified region (scar) markers for plant resistance against fungal pathogens |
| 04/09/2009 | WO2009043178A1 Biomarkers for autism spectrum disorders |
| 04/09/2009 | WO2009043096A1 Improved method for mutagenesis |
| 04/09/2009 | WO2009023855A3 Tetrahydropyran nucleic acid analogs |
| 04/09/2009 | WO2009014766A3 Non-invasive recovery of rna and analysis of gene expression in skin |
| 04/09/2009 | WO2009009127A3 Method and system for transferring and/or concentrating a sample |
| 04/09/2009 | WO2008157572A3 A method of treating abnormal angiogenesis via the bai family of proteins and their protein fragments |
| 04/09/2009 | WO2008140478A3 Compositions and methods for immunodominant antigens |
| 04/09/2009 | WO2008127271A3 Interleukin -13 binding proteins |
| 04/09/2009 | WO2008083327A3 Enrichment through heteroduplexed molecules |
| 04/09/2009 | WO2008070666A3 Compositions and methods to treat cancer with cpg rich dna and cupredoxins |
| 04/09/2009 | WO2008070222A3 A method of surface plasmon resonance (spr) technology to detect genomic disorders for prenatal diagnosis |
| 04/09/2009 | WO2008063760A3 Methods for treating cancer targeting transglutaminase |
| 04/09/2009 | WO2008054834A3 Binary deoxyribozyme probes for nucleic acid analysis |
| 04/09/2009 | WO2008028031A3 Markers and methods for assessing and treating ulcerative colitis and related disorders using a 43 gene panel |
| 04/09/2009 | WO2008025025A3 Antisense composition and method for inhibition of mirna biogenesis |
| 04/09/2009 | WO2008019062A3 Polypeptide derivatives of parathyroid hormone (pth) |
| 04/09/2009 | WO2007134014A3 Compounds and methods for modulating expression of gcgr |
| 04/09/2009 | WO2007091269A3 NOVEL TANDEM siRNAS |
| 04/09/2009 | WO2007041171A3 Method of identifying membrane lg specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells |
| 04/09/2009 | WO2006105277A3 Eg1117 and eg307 polynucleotides and uses thereof |
| 04/09/2009 | WO2006105106A3 Genes controlling winter dormancy in perennials and uses thereof |
| 04/09/2009 | WO2006101520A3 Fluorescent proteins and related methods and compounds |
| 04/09/2009 | WO2006098952A3 Corn event 3272 and methods of detection thereof |
| 04/09/2009 | WO2006086242A3 Mild osteoarthritis biomarkers and uses thereof |
| 04/09/2009 | WO2006079068A3 Compositions and methods for studying and treating inflammatory diseases and disorders |
| 04/09/2009 | WO2006079049A3 Methods and compositions for increased dynamic range detection of nucleic acid molecules |
| 04/09/2009 | WO2006076024A3 A method for targeting synapse with acetylcholinesterase |
| 04/09/2009 | WO2006063031A3 Allelic variants of human factor viii |
| 04/09/2009 | WO2006060790A3 Neoadjuvant genetic compositions and methods |
| 04/09/2009 | WO2006052871A3 Docosahexaenoic acid producing strains of yarrowia lipolytica |
| 04/09/2009 | WO2006046994A3 Klf6 alternative splice forms and a germline klf6 dna polymorphism associated with increased cancer risk |
| 04/09/2009 | WO2006044333A3 Methods and materials for the inhibition of transplant rejection |
| 04/09/2009 | WO2006028684A3 Phytases, nucleic acids encoding them and methods of making and using them |
| 04/09/2009 | WO2006019984A3 Compositions, methods and kits for the diagnosis and treatment of sudden infant death syndrome |
| 04/09/2009 | WO2006017150A3 Identification of markers in lung and breast cancer |
| 04/09/2009 | WO2006014422A3 Polynucleotide encoding a trim-cyp polypeptide, compositions thereof, and methods of using same |
| 04/09/2009 | WO2006007023A3 The ubeg2 binding domain in the ubiquitin ligase gp78 and methods of use thereof |
| 04/09/2009 | WO2006005035A3 Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine pathways in lung cancer cells |
| 04/09/2009 | WO2006002053A3 Helicases |
| 04/09/2009 | WO2005118876A3 Egfr mutations |
| 04/09/2009 | WO2005115102A3 Design, synthesis and assembly of synthetic nucleic acids |
| 04/09/2009 | WO2005112979A3 Methods of preventing and treating alimentary mucositis |
| 04/09/2009 | WO2005108565A3 Modified xylanase, methods of making and use thereof |